Harry Sokol

Molecular Biology · 2008–2021

A researcher in the Science corpus: 17 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 281 citations into it
• Physiology — 54 citations into it

Whom Harry Sokol trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Peter J. Turnbaugh

Who trusts Harry Sokol overall

1. K. Matsuoka
2. June L. Round
3. P. Louis
4. T. Kanai
5. P. Guilloteau
6. S. Mazmanian

Papers from Harry Sokol's perspective

Ordered by how strongly the researchers Harry Sokol trusts endorse each paper. Same corpus, a different order for every researcher.

1. An obesity-associated gut microbiome with increased capacity for energy harvest (Nature)
2. A core gut microbiome in obese and lean twins (Nature)
3. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner (Molecular Psychiatry)
4. Host-Bacterial Mutualism in the Human Intestine (Science)
5. Controlling the false discovery rate: a practical and powerful approach to multiple testing
6. Microbial ecology: Human gut microbes associated with obesity (Nature)
7. A human gut microbial gene catalog established by metagenomic sequencing (Nature)
8. The gut microbiota as an environmental factor that regulates fat storage. (Proceedings of the National Academy of Sciences of the United States of America)
9. Diversity of the Human Intestinal Microbial Flora (Science)
10. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach (Gut)

Their papers

• Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients (2008) — 4,384 citations
• Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment (2012) — 2,570 citations
• Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. (2016) — 757 citations
• Faecalibacterium prausnitzii and human intestinal health. (2013) — 1,110 citations
• The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age (2009) — 1,649 citations
• CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands (2016) — 1,307 citations
• Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease (2015) — 740 citations
• Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. (2018) — 2,559 citations
• Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases (2012) — 837 citations
• Fungal microbiota dysbiosis in IBD (2016) — 1,144 citations
• A microbial signature for Crohn's disease (2017) — 770 citations
• Reporting guidelines for Human Microbiome Research: the STORMS checklist (2021) — 401 citations
• Gut microbiota-derived metabolites as key actors in inflammatory bowel disease (2020) — 1,614 citations
• A structural variation reference for medical and population genetics (2020) — 876 citations
• Gut microbiota-derived metabolites as central regulators in metabolic disorders (2020) — 1,067 citations
• Evaluating drug targets through human loss-of-function genetic variation (2019) — 168 citations
• European consensus conference on faecal microbiota transplantation in clinical practice (2017) — 1,059 citations